Dr. Avo Artinyan, MD

Dr. Artinyan practices at Academic Surgical Associates Inc. in Glendale, California.

Dr. Artinyan's NPI, 1609934942, was assigned on December 5, 2006. Dr. Artinyan graduated from UC San Diego School of Medicine in 2000. Dr. Artinyan holds California license A77942.

Dr. Artinyan's primary practice is Academic Surgical Associates Inc., at 1505 Wilson Ter, Glendale, CA 91206 in Los Angeles County. The practice phone is (818) 484-8611.

Dr. Artinyan's primary practice is Academic Surgical Associates Inc. in Glendale, California. Dr. Artinyan is also affiliated with USC Verdugo Hills Hospital. The medical group on file is Academic Surgical Associates. Dmand AI also links Dr. Artinyan to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Artinyan practices, 4 sites in all. Vendor and product names are available with a free account.

Surgical oncology is Dr. Artinyan's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dr. Artinyan is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Artinyan's licenses on file in 2 states: California and Texas.

Dmand AI lists abdominal adhesion surgery, colon removal and mastectomy among the conditions Dr. Artinyan treats.

CMS data shows 737 Medicare services from Dr. Artinyan across 9 procedure codes in 2024, for 248 Medicare patients. Medicare paid $89,882 for them.

CMS counts 248 Medicare patients who saw Dr. Artinyan in 2024. The largest group is 65 to 74, with 124 patients. 75% of them have arthritis, and 75% have high blood pressure. 92% are also on Medicaid. Their average risk score is 1.93, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Artinyan's median patient age at 60, with 51% women.

In 2024, Dr. Artinyan wrote 180 Medicare Part D claims for 67 patients. 97% of them were for generic drugs. CMS names the drug for 139 of them, across 7 drugs with 11 or more claims each, at $395 in total drug cost. In 2023, CMS named 110 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Artinyan for performance year 2024, reported individually. Dr. Artinyan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 11 procedures of melanoma (skin cancer) excision by Dr. Artinyan, more than 64% of the clinicians it reports for that procedure.

Hernia repair (minimally invasive): 1 to 10 procedures (CMS shows small counts as a range)

Hernia repair - groin (open): 1 to 10 procedures (CMS shows small counts as a range)

Mastectomy: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 48 papers to Dr. Artinyan, published from 2005 to 2022. 2012 was the busiest year, with 6. The most frequent topics are Rectal Neoplasms, Adenocarcinoma and Colorectal Neoplasms. Dr. Artinyan has published most often in Ann Surg Oncol. Dr. Artinyan's most frequent co-authors are Daniel A. Anaya, MD, David Berger, MD and Samir Samuel Awad, MD.

CMS Open Payments shows 64 general payments to Dr. Artinyan from 18 drug and device companies from 2016 to 2025. Education make up the largest share, 57% of the total. Intuitive Surgical, Inc. paid the most, $7,144. It also lists 1 research payment totaling $700 in 2016.

Dmand AI lists 11 awards for Dr. Artinyan, most recently Faculty Excellence Award in 2013.

Dr. Artinyan graduated from UC San Diego School of Medicine in 2000.

Dr. Artinyan is in network with 10 carriers, including Aetna, Elevance and Humana. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.